Day

September 7, 2017

For the 2017–18 season, Medicaid will reimburse up to five monthly palivizumab doses from November 27 through May 15

For the 2017–18 season, Medicaid will reimburse up to five monthly palivizumab doses from November 27 through May 15. Except for the date change to accommodate a Monday start, the eligibility criteria for palivizumab will remain the same as during 2016–17, and will continue to reflect the 2009 AAP criteria (Table).5,6  If the 2017–18 RSV season starts prior to November 27, Medicaid will adjust the coverage dates accordingly.